Skip to content

Text Messaging for Smoking Cessation in College Health Clinics

Text Messaging to Augment Physician Brief Advice for Smoking Cessation in College Health Clinics

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02191033
Enrollment
40
Registered
2014-07-15
Start date
2015-01-31
Completion date
2016-08-31
Last updated
2020-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking

Keywords

cigarette smoking, tobacco use cessation products

Brief summary

This study is a randomized-controlled clinical trial which evaluates the efficacy of physician brief advice, nicotine replacement therapy and a 6-week course of text messaging in promoting cigarette smoking in smokers enrolled in college. The primary hypothesis is that smokers receiving physician brief advice, nicotine replacement therapy, and text messaging will have higher quit rates that smokers receiving physician brief advice and nicotine replacement therapy alone.

Interventions

BEHAVIORALText messaging
DRUGNicotine patch

Sponsors

Southern Connecticut State University
CollaboratorUNKNOWN
University of New Haven
CollaboratorUNKNOWN
Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 24 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged 18 through 24 years * Enrolled as a full/part time college student * A current smoker (Have smoked more than 100 cigarettes in their lifetime and now smoke every day or some days) * English-speaking * Interested in quitting * Have a cell phone for personal use with an unlimited text messaging plan.

Exclusion criteria

* History of hypersensitivity/allergy to nicotine patch; * Serious arrhythmias - History of heart disease (myocardial infarction, severe chest pain, or coronary artery disease) * Current pregnancy/breastfeeding/plan for pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Study Enrollment- Number of Participants Who Join the StudybaselineWe will report the number of persons who join the study.
Study Retention- Number of Participants Who Attend the 6- and 12-week Follow up Visits.6- and 12- weeksWe will determine the number of enrolled participants who follow up at the 6- and 12- week follow up visit.

Secondary

MeasureTime frameDescription
Smoking Abstinence6- and 12- weeksbiochemically confirmed point prevalence of self reported past 7-day abstinence

Countries

United States

Participant flow

Recruitment details

Recruitment open from January 2015 to May 2016. Recruited from local college campuses.

Participants by arm

ArmCount
Text Messaging
Smoking counseling, nicotine patch, text messaging Smoking counseling Text messaging Nicotine patch
20
Standard of Care
Smoking counseling, nicotine patch Smoking counseling Nicotine patch
20
Total40

Baseline characteristics

CharacteristicText MessagingStandard of CareTotal
Age, Continuous19.9 years
STANDARD_DEVIATION 1.7
20.5 years
STANDARD_DEVIATION 1.5
20.2 years
STANDARD_DEVIATION 1.6
Race/Ethnicity, Customized
Race
American Indian/Alaskan Native
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Race
Asian
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Race
Black
2 Participants0 Participants2 Participants
Race/Ethnicity, Customized
Race
White
17 Participants19 Participants36 Participants
Region of Enrollment
United States
20 participants20 participants40 participants
Sex: Female, Male
Female
13 Participants9 Participants22 Participants
Sex: Female, Male
Male
7 Participants11 Participants18 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 200 / 20
serious
Total, serious adverse events
0 / 200 / 20

Outcome results

Primary

Study Enrollment- Number of Participants Who Join the Study

We will report the number of persons who join the study.

Time frame: baseline

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Text MessagingStudy Enrollment- Number of Participants Who Join the Study20 Participants
Standard of CareStudy Enrollment- Number of Participants Who Join the Study20 Participants
Primary

Study Retention- Number of Participants Who Attend the 6- and 12-week Follow up Visits.

We will determine the number of enrolled participants who follow up at the 6- and 12- week follow up visit.

Time frame: 6- and 12- weeks

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Text MessagingStudy Retention- Number of Participants Who Attend the 6- and 12-week Follow up Visits.6-week retention19 Participants
Text MessagingStudy Retention- Number of Participants Who Attend the 6- and 12-week Follow up Visits.12-week retention19 Participants
Standard of CareStudy Retention- Number of Participants Who Attend the 6- and 12-week Follow up Visits.6-week retention20 Participants
Standard of CareStudy Retention- Number of Participants Who Attend the 6- and 12-week Follow up Visits.12-week retention18 Participants
Secondary

Smoking Abstinence

biochemically confirmed point prevalence of self reported past 7-day abstinence

Time frame: 6- and 12- weeks

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Text MessagingSmoking Abstinence6-week3 Participants
Text MessagingSmoking Abstinence12-week1 Participants
Standard of CareSmoking Abstinence6-week5 Participants
Standard of CareSmoking Abstinence12-week1 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026